Skip to main content

Advertisement

Table 4 Response details

From: Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid

Patient Cytologic response (blast count) (%) Hematological improvement Cytogenetic response Response FISH-BM (%) Response FISH-CD34 (%) Mito response (%)
F03 CRi HI-P CR nd CR na
D01 PR (5) HI-N, HI-P, HI-E nd nd nd nd
D03 CRdys HI-N, HI-P, HI-E na na na na
D04 CRdys HI-N, HI-P, HI-E CR CR CR na
D05 CR HI-N, HI-P CR CR PR (1) PR (5)
D06 CRdys HI-P CR CR PR (5) na
D14 CRdys None na na na na
D15 PR (5) HI-P, HI-E CR PR (6) CR CR
D17 CRdys HI-N, HI-P, HI-E CR CR CR CR
F02 SD (CMR) None na na na na
F05 SD (CMR) None None nd none na
D11 SD (CMR) None None none none None
D13 SD (PMR) None na na na None
  1. nd not done, na not applicable